Galera Therapeutics Inc (GRTX) USD0.001

Sell:$0.02Buy:$0.02Price increased$0.00 (6.55%)

Prices delayed by at least 15 minutes
Sell:$0.02
Buy:$0.02
Change:Price increased$0.00 (6.55%)
Deal now
Prices delayed by at least 15 minutes
Sell:$0.02
Buy:$0.02
Change:Price increased$0.00 (6.55%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Galera Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on advancing a pan-NOS inhibitor through clinical development for patients with the hardest-to-treat forms of advanced breast cancer.

Key people

J. Mel Sorensen
Chairman of the Board, President, Chief Executive Officer
Joel F. Sussman
Chief Accounting Officer, Treasurer, Secretary
Michael Friedman
Director
Lawrence M. Alleva
Independent Director
Nancy T. Chang
Independent Director
Kevin Lokay
Independent Director
Click to see more

Key facts

  • Shares in issue
    75.46m
  • EPIC
    GRTX
  • ISIN
    US36338D1081
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $1.66m
  • Employees
    3
  • Exchange
    Over The Counter
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.